Advance Magnetics signs option for imaging agent:
This article was originally published in Clinica
Advance Magnetics has signed an option with privately-owned Cavitation Control Technology for development and marketing rights to Cavitation's lipid microbubble technology for medical applications. First uses will be for a diagnostic contrast agent to detect cancers, including breast, prostate and liver cancer.
You may also be interested in...
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.
A joint report by the US Government Accountability Office and the National Academy of Sciences slams the FDA for dawdling on final software as a medical device rules.